Limonin, an AMPK Activator, Inhibits Hepatic Lipid Accumulation in High Fat Diet Fed Mice

NAFLD is the most prevalent liver disease in human history. The treatment is still limited yet. In the current study, we reported that limonin inhibited hepatic lipid accumulation and fatty acid synthesis in HFD fed mice. Using AMPK inhibitor and AMPK deficient C. elegans, we revealed the effect was...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Si-wei, Lan, Tian, Chen, Hang-fei, Sheng, Hao, Xu, Chun-yi, Xu, Li-feng, Zheng, Fang, Zhang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819594/
https://www.ncbi.nlm.nih.gov/pubmed/35140621
http://dx.doi.org/10.3389/fphar.2022.833705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819594/
https://www.ncbi.nlm.nih.gov/pubmed/35140621
http://dx.doi.org/10.3389/fphar.2022.833705

Ejemplares similares